Pay in 4 interest-free payments of $28.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
12(8):593-600
38)/b11-6+
in a concentration-dependent manner
ZSTK474 treatment inhibits the production of IFNγ and IL-17 in concanavalin A-activated T cells
NMS-P715 Size:Solid 10 mg 12(8):593-600NMS P715 is a selective and orally bioavailable MPS1 inhibitor, which selectively reduces cancer cell proliferation, leaving normal cells almost unaffected. NMS P715 accelerates mitosis and affects kinetochore components localization causing massive aneuploidy and cell death in a variety of tumoral cell lines and inhibits tumor growth in preclinical cancer models. Inhibiting the SAC could represent a promising new approach to selectively target cancer
US$ 13.95
US$ 222.47
US$ 22.00
US$ 24.94
US$ 99.95
US$ 149.50